Intellipharmaceutics International Inc
Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for hyperactivity disorder; Keppra XR, a levetiracetam extended-release tablet for the treatment of partial onset seizures in patients with epilepsy; Effexor XR, a venlafaxine hydrochloride extended-release capsule to treat depression; and Protonix, a pantoprazole sodium delayed-release tablet to treat gastroesophageal reflux disease. It also provides Glucophage XR, a metformin hydrochloride extended-release tablet that treats type 2 diabetes; Seroquel XR, a quetiapine fumarate extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorders; Lamictal XR, a lamotrigine extended release tablet to treat epilepsy; Pristiq, a desvenlafaxine extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; and Ranexa, a ranolazine extended release tablet for chronic angina. In addition, the company is developing OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Regabatin XR, a pregabalin extended-release capsule for the management of neuropathic pain. It has a license and commercialization agreement with Par Pharmaceutical Inc. The company was founded in 1998 and is based in Toronto, Canada. Show More...
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.15 USD
-
Last Updated 24-01-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-11 2011-11 2012-11 2013-11 2014-11 2015-11 2016-11 2017-11 2018-11 2019-11 TTM Earnings Per Share USD -5.3 -3.3 -3.6 -5.8 -1.7 -3.1 -3.8 -2.86 -2.89 -0.37 -0.37 Dividends USD Payout Ratio % * Shares Mil 1.0 1.0 2.0 2.0 2.0 2.0 3.0 3.0 5.0 22.0 22.0 Book Value Per Share * USD 0.09 -1.94 -0.99 -0.64 2.38 0.97 0.59 -0.23 -0.27 -0.1 -0.16 Free Cash Flow Per Share * USD -5.8 -4.83 -5.04 -3.94 -1.25 -1.9 -3.33 -1.83 -2.25 -0.7 Return on Assets % -80.3 -102.58 -140.72 -335.41 -62.94 -113.54 -153.7 -115.25 -145.7 -105.88 -105.88 Financial Leverage (Average) 35.15 1.6 7.14 19.14 2.8 Return on Equity % -243.86 -311.69 -612.54 Return on Invested Capital % -238.57 -184.91 -488.46 -387.94 -356.5 -382.49 -382.49 Interest Coverage -61.12 -3.19 -157.87 -25.74 -10.36 -27.98 -36.54 -15.82 -52.86 -31.68 -31.68 Current Ratio 0.67 2.1 0.42 0.98 2.05 0.56 1.36 0.77 1.64 0.2 0.2 Quick Ratio 0.63 2.05 0.36 0.87 1.91 0.52 1.26 0.69 1.48 0.14 0.14 Debt/Equity 0.010